Minerva Surgical Inc
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally… Read more
Minerva Surgical Inc (UTRS) - Total Liabilities
Latest total liabilities as of September 2023: $52.53 Million USD
Based on the latest financial reports, Minerva Surgical Inc (UTRS) has total liabilities worth $52.53 Million USD as of September 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Minerva Surgical Inc - Total Liabilities Trend (2019–2022)
This chart illustrates how Minerva Surgical Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Minerva Surgical Inc Competitors by Total Liabilities
The table below lists competitors of Minerva Surgical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Securities Trust of Scotland plc
LSE:STS
|
UK | GBX15.59 Million |
|
Botswana Diamonds plc
LSE:BOD
|
UK | GBX1.17 Million |
|
Crown Asia Chemicals Corp
PSE:CROWN
|
Philippines | ₱325.58 Million |
|
NAMIBIAN COPPER
BE:42N
|
Germany | €39.07 Million |
|
One Health Group Plc
LSE:OHGR
|
UK | GBX7.78 Million |
|
Beacon Rise Holdings PLC
LSE:BRS
|
UK | GBX39.02K |
Liability Composition Analysis (2019–2022)
This chart breaks down Minerva Surgical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.59 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Minerva Surgical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Minerva Surgical Inc (2019–2022)
The table below shows the annual total liabilities of Minerva Surgical Inc from 2019 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $51.72 Million | -27.14% |
| 2021-12-31 | $70.99 Million | -77.38% |
| 2020-12-31 | $313.86 Million | +24.94% |
| 2019-12-31 | $251.21 Million | -- |